NCT05121311View on ClinicalTrials.gov

Assessment of Neonatal Hyperbilirubinemia by NeoprediX B.1 Algorithm

CompletedOBSERVATIONAL
Enrollment

455

Participants

Timeline

Start Date

August 9, 2021

Primary Completion Date

November 30, 2021

Study Completion Date

January 31, 2022

Conditions
Newborn Jaundice
Interventions
DIAGNOSTIC_TEST

NeoprediX B1 algorithm

Re-assessement of bilirubin measurements done according to standard of care of the participating center by the NeoprediX B1 algorithm

Trial Locations (2)

72076

University Children's Hospital, Tübingen

93049

KUNO Kinderklinik St. Hedwig, Regensburg

All Listed Sponsors
collaborator

Center for Pediatric Clinical Studies (CPCS)

UNKNOWN

lead

NeoPredix AG

INDUSTRY

NCT05121311 - Assessment of Neonatal Hyperbilirubinemia by NeoprediX B.1 Algorithm | Biotech Hunter | Biotech Hunter